In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune ...

Subclade K, a variant of flu type A H3N2, has caught medical professionals off-guard. It already has spread rapidly in ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

Vivaldi Biosciences Inc., a venture-backed company with operations at the Research Innovation Center at Colorado State University, has been issued a patent for its DeltaFLU universal influenza vaccine ...

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect ...

A mutated strain of influenza A, H3N2 subclade K, is surging worldwide, sparking concerns about a severe flu season in the ...

A new type of seasonal flu virus is raising concerns among health officials as winter approaches. Here's what to know about ...

A new influenza A strain subclade K is circulating due to H3N2 picking up 7 mutations this Summer. Will this lead to a worse ...

Have a fear of needles, or hate having a sore arm after getting the flu jab?A new influenza vaccine administered as a nasal ...

Now you can give yourself a flu vaccine at home. Should you try it? If you have a fear of needles and are nervous about getting the flu shot, you’re not alone. It’s estimated that up to 25% of adults ...

New research comparing four different flu vaccines found that the protection offered varied greatly depending on vaccine type and age of the patient. Researchers say these findings have the potential ...